Switzerland · Seed startup

Who invested in ENANTIOS

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 31 Oct 2026

$2.0Mraised across 1 round since 2024, from 1 source

Latest round
Seed, $2.0MJun 2024
Investors
0
See who backed them

The rounds

  1. Jun 2024
    Seed$2.0M

    No investor was named in the report.

    Source recorded

Founders and team

From ENANTIOS's own website: 2 on the team.

  • Dr. Monika DenglerHead of Scientific Applications
  • Madeleine MarchandBusiness Operations and People Lead

AdvisersDr. Christian JohannessenDr. Daniel SchaufelbergerExperimental Application ScientistPhilip TschoppProf. Dr. David NorrisProf. Dr. Romain Quidant

Also claim to have backed them

These 2 firms list ENANTIOS as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

EuroUS VenturesVC firmPer its own site
Privilège VenturesVC firmPer its own site

Quick answers about ENANTIOS

How much has ENANTIOS raised?

ENANTIOS has raised $2.0M across 1 round since 2024.

When did ENANTIOS last raise?

ENANTIOS's most recent round was a Seed of $2.0M in Jun 2024.

What was ENANTIOS's biggest round?

Its most recent round, $2.0M in Jun 2024, is also its largest on record.

What stage is ENANTIOS at?

ENANTIOS's latest named round is a Seed, in Jun 2024.

Where is ENANTIOS based?

ENANTIOS is based in Switzerland.

Companies like ENANTIOS

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.